Ireland· IE-PA-EU/1/17/1188/002
Spinraza 28 mg solution for injection
A nusinersen product containing nusinersen sodium, registered in Ireland by Biogen Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Nusinersen is registered in 13 of 19 countries.
Countries holding a registration under ATC M09AX07 (nusinersen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Nusinersen · ATC M09AX07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nusinersen costs, country by country.
Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nusinersen · price per daily dose (0.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$531.69
The record
At a glance
HPRA (Ireland)- Active substance
- Nusinersen sodium
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Ireland (IE)
- ATC code
- M09AX07
- ATC class
- Nusinersen
- Defined daily dose
- 0.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1188/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nusinersen in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d63c57ef-3b43-4002-8a09-52ccb7f60f5c GET /v1/drugs/d63c57ef-3b43-4002-8a09-52ccb7f60f5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intrathecal use"
],
"source": "hpra",
"atc_all": [
"M09AX07"
],
"strength": null,
"pa_number": "EU/1/17/1188/002",
"substances": [
"Nusinersen sodium"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "09/01/2026",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about nusinersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.